Human glial chimeric mice reveal astrocytic dependence of JC virus infection

Insights

Researchers created a mouse model for progressive multifocal leukoencephalopathy (PML) by humanizing mouse white matter. This model shows JC virus (JCV) infects astrocytes and glial progenitor cells, leading to PML pathogenesis.

Area of Science:

  • Neuroscience
  • Virology
  • Immunology

Background:

  • Progressive multifocal leukoencephalopathy (PML) is a severe demyelinating disease caused by the human-specific JC virus (JCV).
  • The lack of animal models for JCV infection hinders research into its pathogenesis and treatment development.

Purpose of the Study:

  • To develop a novel animal model for studying JC virus pathogenesis and PML.
  • To investigate the cellular targets and mechanisms of JCV infection in the central nervous system.

Main Methods:

  • Human glial progenitor cells (GPCs) were engrafted into neonatal immunodeficient and myelin-deficient mice to create humanized white matter.
  • Intracerebral inoculation of JC virus (JCV) was performed in these chimeric mice.
  • Infected tissues were analyzed for viral presence, replication, cellular tropism, and host cell responses, including apoptosis and viral mutation.

Main Results:

  • The humanized mice developed JCV infection and demyelination, successfully modeling PML.
  • JC virus primarily infected human astrocytes and GPCs, with viral replication observed in these cells.
  • Oligodendrocytes showed T-antigen expression and apoptotic death, indicating secondary involvement in demyelination.
  • Progressive mutations in the JCV capsid protein VP1 were observed during infection.

Conclusions:

  • Astrocytes and GPCs are the principal central nervous system targets for JCV infection.
  • Astroglial infection is sufficient for JCV propagation, and demyelination is a secondary consequence of oligodendroglial apoptosis.
  • This humanized mouse model provides a valuable platform for studying human-specific gliotropic viruses like JCV and for developing therapeutic strategies.